You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
信邦製藥(002390.SZ):目前公司自建及共建道地藥材基地面積合計超過22萬畝
格隆匯 07-05 08:33

格隆匯7月5日丨信邦製藥(002390.SZ)近期在接待機構調研時表示,在中藥飲片業務板塊,公司制定了“以中藥飲片為主體、大健康產品和中藥材貿易為兩翼”的戰略發展規劃,並始終以質量為中心,依託道地藥材基地,從源頭開始對中藥材進行全面質量管控,在全國率先實現了從種植基地建設、中藥飲片生產到醫療機構使用的無縫鏈接,有效保障了中藥飲片的產品質量、臨牀用藥安全和療效。目前公司自建及共建道地藥材基地面積合計超過22萬畝,在全國擁有122個種植基地,主要種植品種包括黃精、黃柏、虎杖、何首烏、硃砂根等。

在中藥飲片方面,擁有品種138個、品規207個,加工產能達6,000噸/年;在大健康產品方面,已開發出中藥香囊、沐足湯、藥枕、藥食同源保健產品等系列產品;在中藥材貿易方面,在保障自身中藥飲片生產需要的前提下,以貴州為中心輻射西南、以甘肅為中心輻射西北、以安徽為中心輻射中原的道地藥材基地公司也開展道地中藥材貿易業務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account